Trial intelligence / Profile preview

Levothyroxine for Subclinical Hypothyroidism in Elderly

NCT00921050Phase 3Completed

Sponsor
Universidad Autónoma de Nuevo León
Start
Jun 2009
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hypothyroidism comparing Levothyroxine with Placebo (2 arms). Primary endpoints: Change in cognitive ability measured by NEUROPSI at 6 months, Left Ventricular Ejection Fraction at 6 months and 2 more. Started Jun 2009; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NCT00921050.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00921050.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call